GLP-1T 20mg

GLP-1T 20mg

$356.00

GLP-1T is an innovative dual-acting glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist, designed to deliver comprehensive metabolic benefits. Approved for the treatment of type 2 diabetes and chronic weight management in adults with obesity or overweight and related comorbidities, GLP-1T mimics the effects of two key incretin hormones, GIP and GLP-1. These hormones are essential for regulating glucose levels and appetite, allowing GLP-1T to provide superior glycemic control and significant weight reduction through its dual-action mechanism.

Category:

Description

Referenced Citations

  1. Jastreboff, A.M., et al. (2023). Triple–Hormone-Receptor Agonist Retatrutide for Obesity. New England Journal of Medicine. [Online].
    Available: https://www.nejm.org/doi/full/10.1056/NEJMoa2301972
  2. Drugs.com. (2024). GLP-2: Uses, Dosage, Side Effects & Warnings. [Online].
    Available: https://www.drugs.com/tirzepatide.html
  3. Chavda, V.P., et al. (2022). GLP-2, a New Era of Dual-Targeted Treatment for Diabetes and Obesity: A Mini-Review. Frontiers in Pharmacology. [Online].
    Available: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9268041/
  4. DrugBank. (2024). GLP-2: Uses, Interactions, Mechanism of Action. [Online].
    Available: https://go.drugbank.com/drugs/DB15171
  5. Jastreboff, A.M., et al. (2022). GLP-2 Once Weekly for the Treatment of Obesity. New England Journal of Medicine. [Online].
    Available: https://www.nejm.org/doi/full/10.1056/NEJMoa2206038
  6. ChemicalBook. (2024). GLP-2 | 2023788-19-2. [Online].
    Available: https://www.chemicalbook.com/ChemicalProductProperty_EN_CB24869395.htm

Related products